Wild type EGFR trang 1 tải miễn phí từ tailieunhanh

"Wild type EGFR" trang 1 - tải miễn phí từ tailieunhanh

Prognostic value of CYFRA 21−1 and Ki67 in advanced NSCLC patients with wild-type EGFR

Prognostic value of CYFRA 21−1 and Ki67 in advanced NSCLC patients with wild-type EGFR

10 3 1

Treatment patterns and outcomes of patients with metastatic non-small cell lung cancer in five European countries: A real-world evidence survey

Treatment patterns and outcomes of patients with metastatic non-small cell lung cancer in five European countries: A real-world evidence survey

20 1 1

REMARRY and PURSUIT trials: Liquid biopsyguided rechallenge with anti-epidermal growth factor receptor (EGFR) therapy with panitumumab plus irinotecan for patients with plasma RAS wild-type metastatic colorectal cancer

REMARRY and PURSUIT trials: Liquid biopsyguided rechallenge with anti-epidermal growth factor receptor (EGFR) therapy with panitumumab plus irinotecan for patients with plasma RAS wild-type metastatic colorectal cancer

6 55 1

The PANDA study: A randomized phase II study of first-line FOLFOX plus panitumumab versus 5FU plus panitumumab in RAS and BRAF wild-type elderly metastatic colorectal cancer patients

The PANDA study: A randomized phase II study of first-line FOLFOX plus panitumumab versus 5FU plus panitumumab in RAS and BRAF wild-type elderly metastatic colorectal cancer patients

11 78 1

Epidemiological study of HER-2 mutations among EGFR wild-type lung adenocarcinoma patients in China

Epidemiological study of HER-2 mutations among EGFR wild-type lung adenocarcinoma patients in China

7 33 1

Combined treatment of Nimotuzumab and rapamycin is effective against temozolomide-resistant human gliomas regardless of the EGFR mutation status

Combined treatment of Nimotuzumab and rapamycin is effective against temozolomide-resistant human gliomas regardless of the EGFR mutation status

13 46 1

High resolution melting analysis of KRAS, BRAF and PIK3CA in KRAS exon 2 wild-type metastatic colorectal cancer

High resolution melting analysis of KRAS, BRAF and PIK3CA in KRAS exon 2 wild-type metastatic colorectal cancer

10 36 1

EZH2 inhibitors reverse resistance to gefitinib in primary EGFR wild-type lung cancer cells

EZH2 inhibitors reverse resistance to gefitinib in primary EGFR wild-type lung cancer cells

18 47 1

Common driver mutations and programmed death-ligand 1 expression in advanced non-small cell lung cancer in smokers and never smokers

Common driver mutations and programmed death-ligand 1 expression in advanced non-small cell lung cancer in smokers and never smokers

15 1 1